Collection's Items (Sorted by Submit Date in Descending order): 81 to 100 of 208
Preview | Issue Date | Title | Author(s) |
| May-2021 | The Gut Microbiome and Gastrointestinal Toxicities in Pelvic Radiation Therapy: A Clinical Review | Back, Michael ; Eade, Thomas ; Kneebone, Andrew ; Oh, B.; Lamoury, G.; Carroll, S.; Morgia, M.; Hruby, G.; Stevens, M.; Boyle, F.; Clarke, S.; Corless, B.; Molloy, M.; Rosenthal, D. |
| Oct-2021 | A randomized phase II trial of veliparib, radiotherapy, and temozolomide in patients with unmethylated MGMT glioblastoma: the VERTU study | Back, Michael ; Sim, H.W.; McDonald, K.L.; Lwin, Z.; Barnes, E.H.; Rosenthal, M.; Foote, M.C.; Koh, E.S.; Wheeler, H.; Sulman, E.P.; Buckland, M.; Fisher, L.; Leonard, R.; Hall, M.; Ashley, D.M.; Yip, S.; Simes, J.; Khasraw, M. |
| Feb-2021 | Radiation oncology during COVID-19: Strategies to avoid compromised care | Back, Michael ; Horsley, P.J.; Lamoury, G.; Porter, B.; Booth, J.; Eade, Thomas |
| Nov-2020 | Introducing Computed Tomography Simulation-Free and Electronic Patient-Reported Outcomes-Monitored Palliative Radiation Therapy into Routine Care: Clinical Outcomes and Implementation Experience | Back, Michael ; Schuler, T.; Hruby, G.; Carroll, S.; Jayamanne, Dasantha ; Kneebone, Andrew ; Stevens, M.; Lamoury, G.; Morgia, M.; Wong, S.; Grimberg, K.; Roderick, S.; Booth, J.; Eade, Thomas |
| Nov-2021 | Outcomes of retroperitoneal lymph node dissection for testicular cancer by a high volume surgeon from Australia: a case for centralisation | Arasaratnam, Malmaruha ; Williams, I.S.C.; Lahoud, J.; Gurney, H.; Patel, M.I. |
| Oct-2021 | Transrectal ultrasound-guided prostate needle biopsy remains a safe method in confirming a prostate cancer diagnosis: a multicentre Australian analysis of infection rates | Louie-Johnsun, Mark ; Parkin, Cameron J ; Gilbourd, D.; Grills, R.; Chapman, S.; Weinstein, S.; Joshi, N.; Indrajit, B.; Kam, J.; Smilovic, T.; Shepherd, A.; Gikenye, N. |
| 9-Jun-2021 | Redo craniotomy or bevacizumab for symptomatic steroid-refractory true or pseudoprogression following IMRT for glioblastoma | Cook, Theresa A ; Jayamanne, Dasantha ; Wong, Matthew ; Cove, Nicola ; Back, Michael ; Wheeler, H.; Parkinson, J.; Cook, R. J.; Kastelan, M. A.; Brown, C. |
| 16-Sep-2021 | Diffuse large B-cell lymphoma: A consensus practice statement from the Australasian Lymphoma Alliance | Armytage, Tasman ; Wight, J.; Hamad, N.; Campbell, B. A.; Ku, M.; Lee, K.; Rose, H.; Latimer, M.; Lee, H. P.; Lee, S. T.; Dickinson, M.; Khor, R.; Verner, E. |
| Jun-2021 | Concurrent carbogen and nicotinamide with radiation therapy in muscle invasive bladder cancer: A report on feasibility in the Australian setting | Anzela, Anzela ; Min, M.; Knesl, M.; Buddle, N.; Azzopardi, M.; Hooshmand, R.; Barrett, S.; Notman, A.; Woolls, H.; Wilson, J.; Vignarajah, D.D. |
| Jun-2021 | Patterns of care and outcomes of men with germ cell tumors in a high-volume Australian center | Arasaratnam, Malmaruha ; Balakrishnar, B.; Crumbaker, M.; Turner, S.; Hayden, A.J.; Brooks, A.; Patel, M.I.; Woo, H.; Bariol, S.; Lau, H.; Gurney, H. |
| Sep-2020 | Melphalan exposure and outcome in obese and non-obese adults with myeloma. A study of pharmacokinetics and pharmacodynamics | Tiley, Campbell ; Nath, C.E.; Trotman, J.; Nivison-Smith, I.; Gurney, H.; Zeng, L.; Presgrave, P.; Joshua, D.; Kerridge, Ian ; McLachlan, Andrew ; Shaw, P.J. |
| Feb-2021 | A novel quality assurance procedure for trajectory log validation using phantom-less real-time latency corrected EPID images | Zwan, Benjamin ; Lim, S.B.; Lee, D.; Greer, P.B.; Lovelock, D.M. |
| Jan-2021 | "SQiD, the Single Question in Delirium; can a single question help clinicians to detect delirium in hospitalised cancer patients?" running heading Single Question in Delirium" (Bcan-D-20-01665) | Buchanan, Angus M ; Sands, M.B.; Sharma, S.; Carpenter, L.; Hartshorn, A.; Lee, J.T.; Lujic, S.; Congdon, M.E.; Agar, M.; Vardy, J.L. |
| Jan-2008 | Outcome of patients with head and neck cancers: 10-year experience of a otorhinolaryngology--head and neck unit in a tertiary hospital of a developing country | Shashinder, Singh ; Choo, P.K.; Gopala, K.G. |
| Mar-2009 | A review of parotid tumours and their management: a ten-year-experience | Shashinder, Singh ; Tang, I.P.; Velayutham, P.; Prepageran, N.; Gopala, K.G.; Kuljit, S.; Anura, M.M.; Chong, S.Y. |
| Dec-2009 | Velopharyngeal stenosis, a late complication of radiotherapy | Shashinder, Singh ; Lee, S.C.; Tang, I.P.; Singh, A.; Kumar, S.S. |
| Jan-2011 | A recurrent nasopharyngeal carcinoma with lacrimal sac involvement: a case report | Shashinder, Singh ; Tang, I.P.; Periyannan, P.; Prepageran, N.; Singh, A.; Bhagubhai, P.N. |
| Jul-2014 | Symptomatic Histologically Proven Necrosis of Brain following Stereotactic Radiation and Ipilimumab in Six Lesions in Four Melanoma Patients | Chan, Matthew M K ; Du Four, S.; Hong, A.; Charakidis, M.; Duerinck, J.; Wilgenhof, S.; Wang, W.; Feng, L.; Michotte, A.; Okera, M.; Shivalingam, B.; Fogarty, G.; Kefford, R.; Neyns, B. |
| Nov-2015 | Clinicopathologic features associated with efficacy and long-term survival in metastatic melanoma patients treated with BRAF or combined BRAF and MEK inhibitors | Chan, Matthew M K ; Menzies, A.M.; Wilmott, J.S.; Drummond, M.; Lo, S.; Lyle, M.; Thompson, J.F.; Guminski, A.; Carlino, M.S.; Scolyer, R.A.; Kefford, R.F.; Long, G.V. |
| Nov-2015 | A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer trials group NITRO trial | Chan, Matthew M K ; Davidson, A.; Veillard, A.S.; Hughes, B.G.; Boyer, M.; Briscoe, K.; Begbie, S.; Abdi, E.; Crombie, C.; Long, J.; Boyce, A.; Lewis, C.R.; Varma, S.; Broad, A.; Muljadi, N.; Chinchen, S.; Espinoza, D.; Coskinas, X.; Pavlakis, N.; Millward, M.; Stockler, M.R. |
Collection's Items (Sorted by Submit Date in Descending order): 81 to 100 of 208